Submit Deal

AGENT CAPITAL

Summary

Agent Capital a biotech venture capital firm.

Deals Overview

Total Deals8

Valued Deals8

Total Value£871M

Avg. Deal Size£109M

Market Context

Senior Management

Geeta Vemuri
managing Partner and Founder

Deals (8)

Service Providers

Relationships

Portfolio

Team

Sort

United States

Biotechnology

Cross BorderAcquisitionVenture CapitalPrivatePrivate EquityMinority

target

Pyxis Oncology

bidder

Rtw Investments

£110m

5 dealmakers

United States

Biotechnology

MinorityCross BorderPrivateAcquisitionVenture CapitalPrivate Equity

target

Entrada Therapeutics

bidder

Wellington Management

£84m

29 dealmakers

United States

Biotechnology

AcquisitionMinorityDomesticVenture CapitalPrivatePrivate Equity

target

Affini-t Therapeutics

bidder

Erasca Ventures

£132m

6 dealmakers

France

Biotechnology

Venture CapitalPrivateAcquisitionPrivate EquityMinorityCross Border

target

Imcheck Therapeutics

bidder

Agent Capital

£91m

17 dealmakers

United States

Biotechnology

AcquisitionVenture CapitalPrivatePrivate EquityCross BorderMinority

target

Carbon Biosciences

bidder

Astellas Venture Management

£30m

15 dealmakers

United States

Biotechnology

Venture CapitalAcquisitionMinorityPrivate EquityPrivateDomestic

target

Zenas Biopharma

bidder

Agent Capital

£103m

14 dealmakers

United States

Biotechnology

Venture CapitalPrivateAcquisitionPrivate EquityMinorityCross Border

target

Flare Therapeutics

bidder

Memorial Sloan Kettering Cancer Center

£100m

6 dealmakers

United States

Biotechnology

MinorityDomesticVenture CapitalAcquisitionPrivate EquityPrivate

target

Orbital Therapeutics

bidder

Newpath Partners

£216m

4 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.